About Us

Our mission

BorMedicals is well aware that an sector-specific information service provider that can go further must grow together and align well with that sector. While large players remain the barometer of standards and trend of the industry, it is often the start-ups that can transform and disrupt the industry. China's health-care sector is still in infancy, and BorMedicals is committed to providing a platform to grow together with young medical enterprises.

BorMedicals is a team focusing on the health-care sector under Borscon Group. We are committed to contributing our value to global health-care sector, and also dedicated to supporting health-care start-ups, connecting global health-care elites, reducing the costs of information exchange, providing an integrated online and offline platform, and building a big bio-pharmaceutical ecosystem in the era of great health-care.

Our vision

Become the No.1 information platform in China's health-care industry

Our values

Responsibility, innovation, leadership, execution

International Vaccine & Biotech 4.0 Forum (IVB4.0) is a merger of China International Vaccine Innovation Summit (HVIS) and China International Biopharma 4.0 Summit (CIBP4.0). Among them, HVIS has already become the largest and most influential vaccine industry segmentation summit in China after only two sessions, and CIBP4.0 has gained an excellent user reputation at the third CIBP4.0 Summit in 2021 after three years of cultivation.

IVB4.0 aims to link global elites through forums and online platforms, eliminate the cost of information exchange, help support biopharmaceutical startups and promote the development of the industry. At present, BOMAX Biopharma Summit Series has accumulated 5000+ professional customers to attend offline. IVB4.0 2023 will have about 100 speakers and judges, 150+ exhibitors at the Vaccine & Biotech Show, and 5,000+ target attendees. Our goal is to make IVB4.0 the most influential pharmaceutical industry summit in China.

Best Start-UP Awards (BSA) is a competition for startups in the healthcare industry, launched by BMS in 2021 and open to the whole country. Based on Bormedicals's years of accumulation in the biopharmaceutical industry, BSA will bring together the most authoritative experts, medical business dark horses, industry leaders and senior media.

BSA will track and analyze a large number of startup cases in the medical industry and focus on scientific definition of business model, team, technology trend and investment potential in the medical field, establish a framework evaluation system for medical startups, and comprehensively evaluate the innovation ability, business model, team, technology ability and development prospect of Chinese medical companies. BSA aims to promote the transformation of Chinese healthcare companies' business innovation and scientific research results, and to provide high reference value investment guidelines for domestic and foreign investors.

Bormedicals online platform

Bormedicals's online platform consists of two major parts: online video and community. Our online video is mainly the video number and online lecture series, which has accumulated 50,000+ plays.

Bormedicals has several vertical communities in the medical industry with a total of 5000+ precise professionals in the medical industry. By 2024, the number of Bormedicals's medical industry communities will exceed 2w+. Empowering industry information promotion to meet customers' promotion needs.

New Media

Bormedicals has two public numbers, "Borscon Medical News" and "Borscon Devices".

We publish selected information of biomedical industry and medical device industry every day. New media is the last kilometer of the closed loop of Bormedicals's medical information platform. We aim to use new media to continue the connection with our customers and spread the influence.